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The adaptation of Salmonella enterica to the eukaryotic host is a key process that 
enables the bacterium to survive in a hostile environment. Salmonella have evolved 
an intimate relationship with its host that extends to their cellular and molecular levels. 
Colonization, invasion, and replication of the bacteria in an appropriate host suggest 
that modification of host functions is central to pathogenesis. Intuitively, this subversion 
of the cell must be a complex process, since hosts are not inherently programmed to 
provide an environment conducive to pathogens. Hosts have evolved countermeasures 
to pathogen invasion, establishment, and replication through two types of defenses: 
resistance and tolerance. Resistance functions to control pathogen invasion and reduce 
or eliminate the invading pathogen. Research has primarily concentrated on resistance 
mechanisms that are mediated by the immune system. On the other hand, tolerance 
is mediated by different mechanisms that limit the damage caused by a pathogen’s 
growth without affecting or reducing pathogen numbers or loads. The mechanisms of 
tolerance appear to be separated into those that protect host tissues from the viru-
lence factors of a pathogen and those that limit or reduce the damage caused by the 
host immune and inflammatory responses to the pathogen. Some pathogens, such as 
Salmonella, have evolved the capacity to survive the initial robust immune response and 
persist. The persistent phase of a Salmonella infection in the avian host usually involves 
a complex balance of protective immunity and immunopathology. Salmonella is able to 
stay in the avian ceca for months without triggering clinical signs. Chronic colonization 
of the intestinal tract is an important aspect of persistent Salmonella infection because 
it results in a silent propagation of bacteria in poultry stocks due to the impossibility to 
isolate contaminated animals. Data from our lab promote the hypothesis that Salmonella 
have evolved a unique survival strategy in poultry that minimizes host defenses (dis-
ease resistance) during the initial infection and then exploits and/or induces a dramatic 
immunometabolic reprogramming in the cecum that alters the host defense to disease 
tolerance. Unfortunately, this disease tolerance results in the ongoing human food safety 
dilemma.
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iNTRODUCTiON
Salmonella infection and Poultry
Foodborne illness is a significant worldwide public health problem 
that continues to plague the world, costing approximately $152 
billion annually (1). Despite control efforts that cost over a half a 
billion dollars annually, foodborne illnesses due to Salmonella and 
Campylobacter increased during the last 15 years. In 2013, 20% 
of the 9.4 million episodes of foodborne illnesses were attributed 
to Salmonella and accounted for 26% of the hospitalizations (2). 
In 2012, the Foodborne Diseases Active Surveillance Network 
found that Salmonella accounted for over 28% of the confirmed 
foodborne disease cases in the U.S., and cost U.S. residents $14.6 
billion annually, respectively (3). Clearly, efforts to elucidate and 
implement new and existing methods for control are well justified 
by the economic cost alone to control Salmonella, Campylobacter, 
and other foodborne pathogens. Poultry products have been 
associated frequently and consistently with the transmission of 
enteric pathogens, including Salmonella and Campylobacter (4).
Salmonellosis is a zoonotic disease caused by the Gram-negative 
facultative anaerobic, enteric bacterium Salmonella. With more 
than 2,500 serotypes having been described, most Salmonella 
serovars are not restricted to particular host species and are able 
to colonize the alimentary tract of animals without production of 
disease (5). Not coincidentally, the most common human clinical 
isolates, Salmonella enterica serotypes Typhimurium (STm) and 
Enteritidis (SE), are the most commonly detected serotypes in 
poultry (6).
In poultry, S. enterica serotypes can be divided into two groups 
based on their host species range and their disease pathogenesis 
(5, 7, 8) with S. enterica serotypes S. Gallinarum and S. Pullorum 
being chicken-specific and the broad host serovars best exempli-
fied by STm and SE. STm and SE are major causes of zoonotic 
gastroenteritis in a wide range of host species worldwide (5–8).
Both broad host range Salmonella serovars (STm and SE) are 
able to colonize the gastrointestinal tract of chickens a few days 
of age without clinical disease but induce a rapid (within 4  h) 
and mild acute inflammatory response (9). After oral infection 
of fowl, the bacterial colonization is durable in the gut where the 
two ceca represent a suitable site for colonization. Salmonella 
can be transmitted horizontally within the flock after fecal 
shedding as well as vertically through the trans-ovarian route. 
Chicks are more susceptible to salmonellosis than adults. In 
particular, asymptomatic carriers have a major role in Salmonella 
propagation in poultry and hence in food contamination, since 
they cannot be easily isolated and identified. The persistence of 
Salmonella in the intestinal tract of chickens is the main cause of 
disease propagation in poultry (5, 8, 9).
PeRSiSTeNCe OF Salmonella iNTeSTiNAL 
COLONiZATiON
Infection with a pathogenic microorganism usually results in the 
host responding by activating the innate and adaptive immune 
responses. However, some pathogens, such as Salmonella, have 
evolved the capacity to survive the initial robust immune response 
and persist (10–12). The persistent phase of infection usually 
involves a complex balance of protective immunity and immu-
nopathology. The interactions between the host and pathogen are 
very complex and likely reflect the coevolution and fine tuning 
of bacterial virulence mechanisms and host immune responses 
(13). Until recently, very little is known about the molecular 
regulatory interactions between the host immune response and 
virulence mechanisms that lead to S. enterica persistence in the 
avian intestine. The carrier state, corresponding to a persistent 
colonization of the gut, is established, and Salmonella is able to 
stay in the ceca for months without triggering clinical signs (14). 
Chronic colonization of the intestinal tract is an important aspect 
of persistent Salmonella infection because it results in a silent 
propagation of bacteria in poultry stocks due to the impossibility 
to isolate contaminated animals (15, 16).
The establishment of persistence is in the face of a substan-
tial immune response requiring evasion or modulation of the 
response by the bacteria. The fact that many Salmonella serovars 
persist within the chicken intestinal tract with little sign of gas-
trointestinal disease despite eliciting a considerable inflammatory 
response and that inflammatory responses to Salmonella are 
relatively short-lived (17), strongly suggests there is a degree of 
regulation of this response.
HOST DeFeNSe STRATeGieS
Historically, host defense strategy has been based on the out-
come of the immune response’s ability to detect and eliminate 
pathogens through multiple killing mechanisms known as host 
resistance (18, 19). However, a relatively new immunological 
concept, tolerance as a host defense strategy has been put forward 
(19, 20). Tolerance is the ability of the host to limit the damage 
caused by both the pathogen and the host immune response, i.e., 
immunopathology (20). Tolerance, as a host defense strategy, has 
been ignored in veterinary infectious disease studies (18). It is 
important to point out that infection tolerance is not immune 
tolerance which is defined as “unresponsiveness of the immune 
system to substances or tissue that has the capacity to elicit an 
immune response” (21).
Unlike immune responses that have measureable outputs to 
evaluate effectiveness, disease tolerance lacks clear-cut outputs 
(18). However, measurement of local cell metabolic processes 
and function, redox status, concentrations of metabolites, and 
organelle function of parenchymal cells and tissues (host’s cells/
tissues that do not have a direct impact on pathogens) would 
be beneficial in evaluating stress and damage responses. Since a 
pathogen and the induced immunopathology can theoretically 
affect any physiological system, disease tolerance would involve 
a number of processes that will reduce host susceptibility to 
damage. Therefore, any physiological mechanism that typically 
maintains homeostasis and functional integrity of host tissues 
could contribute to disease tolerance. Mechanistically, limiting 
tissue damage is regulated by a number of evolutionarily con-
served stress and/or damage responses. These responses confer 
tissue damage control, by providing cellular adaptation to envi-
ronmental changes (22). For example, stress responses maintain 
cellular functions by activating metabolic processes in response 
to local alterations in oxygen tension (hypoxia), redox status 
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(oxidative stress), osmolarity, and metabolite concentrations 
(ADP/ATP, glucose). All are essential mechanisms of cell and 
tissue homeostasis (23). Damage responses attempt to preserve 
cellular functions while minimizing damage to macromolecules 
(DNA, lipids, and proteins) and/or organelles (mitochondria, 
Golgi, and endoplasmic reticulum) (19, 23). The concept of toler-
ance as a host defense mechanism has led to an excellent recent 
editorial (24). The authors ask a very provocative question of what 
effect does therapeutics based on reducing the symptoms induced 
by a pathogen (tolerance) instead of reducing pathogen numbers 
have on evolution of the host population and the pathogen? By 
not reducing pathogen numbers, will there be an effect on patho-
gen transmission and spread and the potential development of 
disease carriers or will the limitation of disease symptoms allow 
the host immune system to concentrate on controlling pathogen 
numbers?
Salmonella-CHiCKeN iNFeCTiON 
BiOLOGY
Salmonella can be carried by poultry with virtually no ill effects on 
the host; whereas, in humans, the same bacteria cause pathologi-
cal inflammation (25, 26). The induction of this severe inflam-
mation appears to be essential for the salmonellae organisms to 
procure critical nutrients and respiratory substrates from the host 
allowing the pathogen to out-compete the commensal microbiota 
that rely on anaerobic fermentation (27–29). Thus, the interac-
tions between the host response and Salmonella infections in the 
intestinal tract of poultry appear to be directed toward disease 
tolerance characterized by the asymptomatic nature of infection. 
Therefore, the chicken and bacteria appear to have evolved a 
relationship that minimizes both the normal host response and 
the normal bacterial virulence. However, this tolerant state is 
“detrimental to food safety” in humans (30).
In a recent review, Wigley (9) described how Salmonella 
infection in chickens facilitated our understanding of avian 
immunology over the last 20+ years. At the end of his review, 
Wigley (9) asked a “few key questions that still needed to be 
fully answered.” We have used two of the questions for the basis 
of our studies into the persistence of colonization of Salmonella 
in the intestine of chickens. Namely, (1) what mechanisms trig-
ger the persistence of Salmonella in the cecum and (2) how is 
the intestinal response regulated to prevent excessive damage 
to the host? The Salmonella-chicken dynamics provide a unique 
system where the pathogen appears to evade the immune 
system, alters the local intestinal phylogeny of recognition 
and signaling pathways, and takes residence amongst the cecal 
microbiota.
Based on the findings by us and others, we propose that 
Salmonella infection in the chicken can be separated into three 
distinct stages of host defense strategies characterized by the cecal 
immune effector cells, immune gene expression, and immuno-
metabolic responses at different times postinfection:
 1. Stage 1, Disease Resistance: characterized by an acute het-
erophil-mediated pro-inflammatory response and anabolic 
metabolism 1–2 days postinfection.
 2. Stage 2, Disease Tolerance: exemplified by a profound an increase 
in cecal T regulatory cells and an anti-inflammatory response 
and a conversion to a catabolic phenotype 4 days postinfection.
 3. Stage 3, Homeostasis: a return to a homeostatic metabolic 
phenotype with a more IL-10-mediated regulatory immune 
response 5–10 days postinfection.
STAGe 1, DiSeASe ReSiSTANCe
Salmonella invasion of the chicken intestine induces an inflam-
matory process resulting in the expression of pro-inflammatory 
cytokines and chemokines by epithelial cells lining the intestine 
(17, 31–33). The outcome of this activation of innate immunity is 
a major influx of heterophils (granulocytes) to the intestine that 
limits bacterial invasion (34, 35) but does not lead to a patho-
logical inflammation that is seen in humans (17, 36). However, 
this heterophil response does not have a significant protective 
response against the salmonellae bacteria that remain in the 
lumenal side of the cecal epithelium. Interestingly, this inflam-
matory response is largely resolved by 3–4  days postinfection 
(35, 37, 38) characterized by the reduction of pro-inflammatory 
cytokines mRNA transcription in the cecum to non-infected 
control levels yet Salmonella can persist in the intestine and be 
shed in the feces for several weeks (17).
Accompanying intestinal inflammation are extreme altera-
tions in tissue metabolism, most of which are due to the incom-
ing heterophils and other inflammatory cells and can include 
the increase in fatty acid, protein synthesis, glycolysis and the 
production of reactive oxygen intermediates (38, 39). Energy-
demanding processes, such as migration, phagocytosis, and the 
generation of an oxidative burst, that accompany the recruitment 
of the heterophils to the site of infection, trigger transcriptional 
and translational changes in tissue phenotype (predominately 
the metabolic signaling pathway of mTOR phosphorylation) that 
shifts fundamental changes to the local intestinal tissue to ana-
bolic metabolism (37–39). Further, the presence of the PMNs and 
subsequent metabolic requirements exhaust the microenviron-
mental oxygen to quantities nearing anoxia (39). This localized 
oxygen depletion leads to the stabilization, and thus the activation 
of the transcription factor, hypoxia-inducible factor-α (HIF1α), 
and activation of the HIF1α signaling pathway that resolves 
inflammation, and potentially provides a more tolerant local 
setting for the bacteria (40, 41). Under these oxygen-deprived 
conditions, HIF1α activation inhibits mTOR activity resulting 
in a potent anti-inflammatory microenvironment through the 
production and stimulation of T regulatory cells would regulate 
tissue damage (42, 43).
The initial inflammatory response (disease resistance) is suf-
ficient to help control invasion and elicit the development of a 
protective acquired immune response that can lead to systemic 
and eventual clearance of gastrointestinal infection.
STAGe 2, DiSeASe TOLeRANCe
immunological Phenotype
It has been demonstrated by numerous groups that early cecal 
pro-inflammatory (disease resistance) signals following initial 
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infection with STm or SE was dramatically downregulated 
2–4 days after infection that is linked with the development of an 
anti-inflammatory, Th2 response (15, 17, 32, 34, 44) to increased 
expression of IL-10 and TGF-β, which suggests the end of the 
disease resistance and the start of a disease tolerant state were 
being initiated.
It would seem likely that regulation of inflammatory immune 
responses, presumably by regulatory T  cells (Tregs), allows 
Salmonella to persist within the gut for a number of weeks 
without disease to the bird. Such a “tolerogenic” response 
would have little or no impact on the bird itself but has public 
health consequences in allowing persistence for several weeks, 
particularly given broiler chickens are typically slaughtered at 
around 5 weeks of age. Subsequently, we have found an expansion 
of the CD4+ CD25+ T cell (Treg) population in the cecum of 
Salmonella-infected chickens (45). Functionally, the cecal Tregs 
had increased suppressive activity for T effector cells and had a 
profound increase in IL-10 mRNA transcription. In the murine 
model of ST infection, the ability of the bacteria to persist or be 
cleared has been found to be dependent on the presence and 
function of Tregs (46).
Mechanistically, in a series of experiments using a chicken-
specific kinome array, the plasticity of the local cecal immune 
phenotype where the initial inflammatory response against a 
Salmonella infection is then followed by a striking alteration in 
the immune microenvironment 2 days later during the establish-
ment of a persistent Salmonella infection (35, 37, 38). We used 
the power of a species-specific kinome array to delineate the 
mechanisms that alter the host avian inflammatory responses and 
uncover host signaling events that are manipulated by the bacte-
ria in order to establish a persistent infection. First, we found that 
the establishment of a persistent Salmonella cecal colonization 
in chickens activates both the canonical (Smad-dependent) and 
non-canonical (Smad-independent) TGF-β signaling pathways 
(35). TGF-β functions by controlling immune responses by sup-
pressing non-Treg function and promoting Treg function. These 
results are suggestive of a change in the cecal mucosal phenotype 
from pro-inflammatory to tolerance is, in part, mediated by 
the increased expression of TGF-β that activates both Smad-
dependent and -independent TGF-β pathways that increases 
the differentiation and function of Tregs while decreasing the 
function of pro-inflammatory immune cells. Second, during the 
establishment of a persistent Salmonella cecal infection, we found 
the activation of the non-canonical Wnt signaling pathways (35). 
Non-canonical Wnt signaling controls nuclear localization of 
nuclear factor of activated T cell (NFAT) transcriptional factor. 
NFAT regulates the interaction of the innate immune cells with 
acquired immunity to promote anti-inflammatory programs 
and is essential for both development and function of Tregs 
(47, 48). The transformation in the avian host response from 
resistance to tolerance during the establishment of Salmonella 
persistence was further confirmed by a study showing two select 
host immune signaling pathways were altered; namely, the T cell 
receptor and JAK–STAT signaling pathways (38). Both signaling 
pathways were shown to have alterations in the phosphorylation 
of multiple peptides that resulted in the inactivation of an active 
immune response in the local cecal environment. The response 
was characterized by the dephosphorylation of phospholipase 
c-γ1 that induced the dephosphorylation (inhibits activation) 
of NF-κB signaling, thus preventing activation of immune 
response genes and the phosphorylation of NFAT signaling 
which activates anti-inflammatory cytokine production as 
described above. Further, interferon-gamma production that is 
central in the resolution of Salmonella infections in the cecum 
of avian species (16, 32, 49) was also found to be inhibited in 
the cecum of SE-infected chickens through the disruption of 
the JAK–STAT signaling pathway (dephosphorylation of JAK2, 
JAK3, and STAT4). The JAK–STAT signaling pathway transmits 
information from extracellular chemical signals to the nucleus 
resulting in DNA transcription and expression of genes involved 
in immunity, proliferation, differentiation, and apoptosis (50, 51). 
Taken together, by 4 days postinfection, the immune phenotype 
in the cecum of Salmonella-infected chickens has undergone a 
dramatic alteration in host responsiveness where the host does 
not appear to recognize the bacterium as a pathogen resulting in 
a persistent cecal colonization.
Metabolic Phenotype
Concurrently to the alterations in the local immune response 
during the tolerance phase, profound metabolic phenotype altera-
tions occurred in the cecal tissue of Salmonella-infected chickens 
from the early resistance response (4–48 h postinfection) which 
is pro-inflammatory, fueled by glycolysis and mTOR-mediated 
protein synthesis to the later tolerance phase (4 days postinfec-
tion) where the local environment has undergone an immune-
metabolic reprogramming to an anti-inflammatory state driven 
by adenosine monophosphate-activated protein kinase (AMPK)-
directed oxidative phosphorylation (37). Therefore, metabolism 
appears to provide a potential measurement that characterizes 
a state of infection tolerance. Additionally, these results provide 
further evidence of what Olive and Sassetti (52) describe as a 
pathogen’s ability to “sense the metabolic environment of the 
host, adapting to changing nutrient availability.” Further, these 
phosphorylation alterations at the gut level during the first 
3 weeks after infection of day-old broilers with ST appear to lead 
to key metabolic changes that affected fatty acid and glucose 
metabolism through the 5′-AMPK and the insulin/mTOR signal-
ing pathway in the skeletal muscle were altered (53). Supplemental 
proof for the effects of fatty acid and glucose metabolism on 
long-term persistence of Salmonella was recently demonstrated 
using the murine macrophage model (54, 55). ST preferred living 
in alternatively activated macrophages that require the activation 
of the transcription factor, peroxisome proliferator-activating 
receptor δ (PPARδ), which regulates fatty acid metabolism (54). 
Thus, the bacteria prefer macrophages that employ oxidative 
metabolism for energy instead of glycolysis due to the factor that 
disruption of glycolysis is a signal of the activation of the NLRP3 
inflammasome and the subsequent initiation of inflammatory 
cell death, pyroptosis (55).
STAGe 3, HOMeOSTASiS
Immunologically, the third stage of an avian Salmonella infection 
occurs shortly after day 4 postinfection with the expression of a 
TABLe 1 | immunometabolic alterations in the chicken cecum during the 
establishment of a persistent infection.
Parameter Stage 1
Days 1–2 
postinfection
Disease resistance
Stage 2
Days 3–4 postinfection
Disease tolerance
Stage 3
Days 5–28 
postinfection
Homeostasis
Cytokines Pro-inflammatory (17, 
31–33)
IL-10, TGF-β (17, 32, 44) IL-17, IL-10
Immune cells Heterophils (34, 35), 
M1 macrophages 
(55)
Th2 T-helper cells (15), 
regulatory T cells (Tregs) 
(45), M2 macrophages 
(54)
Tregs, APCs
Signaling Toll-like receptor, 
NOD receptor, HIF1 
(40, 41), NF-κB (38)
Smad, Wnt (35), nuclear 
factor of activated T cell 
(47, 48), JAK–STAT (38)
Maintenance
Metabolism Increased fatty acid 
synthesis, protein 
synthesis, glycolysis, 
reactive oxygen 
intermediates (38, 39)
Oxidative 
phosphorylation, fatty 
acid catabolism (53)
Aerobic
Metabolic 
signaling
mTOR (37–39) Adenosine 
monophosphate-
activated protein kinase 
(37)
Energy neutral
Energy 
balance
AMP:ATP AMP:ATP AMP:ATP
Oxygen state Hypoxia (43) Normoxia Normoxia
Metabolic 
state
Anabolic Catabolic Balanced
Immune 
state
Inflammation Anti-inflammatory 
(tolerance)
Non-
inflammatory
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disease tolerance state. The number of Tregs in the cecum of the 
infected birds remains constant suggesting an immune regulation 
state further evidenced by the increased transcription of IL-10 
and TGF-β (37, 38, 44, 45). The underlying question here is 
whether Salmonella is no longer “sensed” by the immune system 
as foreign invaded and has become a component of the cecal 
microbiome. Experiments to answer this question are ongoing 
in our laboratories.
Metabolically, the local microenvironment appears to go 
through a final reprogramming during this third stage of infection 
moving from a catabolic state in stage 2 to a more homeostatic 
status. This was verified in our kinome studies by the fact that we 
observed no differences in the metabolic signaling pathways in 
the ceca from the Salmonella-infected and non-infected chickens 
(37, 38, 44).
PeRSPeCTive
The data from our lab and others soundly support the hypoth-
esis that Salmonella have evolved a unique survival strategy in 
poultry that minimizes host defenses (disease resistance) during 
the initial infection and then exploits and/or induces a dramatic 
immunometabolic reprogramming in the cecum that alters the 
host defense to disease tolerance (summarized in Table  1). 
The ability to induce a state of disease tolerance is unique to the 
poultry-Salmonella interactome in that it allows the bacterium 
to establish a long-term persistent infection in the cecum while 
allowing the host to control disease pathology. Unfortunately, 
it also results in the ongoing human food safety dilemma. It 
should be pointed out that the energy balance reported in 
Table 1 is not backed by direct evidence in these experiments 
but is an assumption based on the fact that AMP is elevated 
when AMPK is activated and ATP is elevated when mTOR is 
activated.
These studies have used the emerging field of immunome-
tabolism at the tissue level to identify potential mechanisms by 
which the host can tolerate a Salmonella infection. Recently, an 
immunometabolic mechanism for disease tolerance to a murine 
STm infection was found to involve the microbiome and the insu-
lin-signaling pathway (56). Taken together, identifying potential 
molecular mechanisms of disease tolerance as a host defense can 
not only “provide a perspective into the evolutionary forces that 
have driven coevolution” (56) of host–pathogen interactions but 
also provide the discovery of new therapeutic targets to control 
foodborne pathogens.
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